Islet transplantation: A realistic alternative for the treatment of insulin deficient diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 66, Issue SUPPL., 2004, Pages

  Kim, Kwang Won ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

Diabetes mellitus; Insulin deficiency; Islet transplantation

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNIVERSITY OF WISCONSIN SOLUTION; VASCULOTROPIN;

ALLOGRAFT; ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CELL ISOLATION; CELL SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; GRAFT FAILURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERVENTIONAL RADIOLOGY; ORGAN PRESERVATION; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; POSTOPERATIVE PERIOD; PURIFICATION;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 9644289533     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.10.025     Document Type: Conference Paper

References (16)

1. World Health Report, World Health Organization, 2002.
2. DCCT Reach Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med. 329 (1993) 977-986.
3. UKPDS Group, Intensive blood-glucose control with sulfonylurea or insulin compared with conventional treatment(UKPDS 33), Lancet 352 (1998) 837-853.
4. Fioretto P., Steffes M.W., Sutherland D.E.R., et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N. Eng. J. Med. 339:1998;69-75
5. Kelly W.D., Lillehei R.C., Merkel F.K., Idezuki Y., Goets F.C. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery. 61:1967;827-837
6. International Pancreas Transplant Registry, IPTR Annual Report 2001.
7. Weir G.C., Bonner-Weir S. Scientific and political impediments to successful islets transplantation. Diabetes. 46:1997;1247-1256
8. Shapiro A.M.J., Lakey R.T.J., Ryan E.A., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:2000;230-238
9. Kuroda Y., Tanioka Y., Morita A., et al. Protective effect of preservation of canine pancreas by the two-layer (University of Wisconsin solution/perfluorochemical) method against rewarming ischemic injury during implantation. Transplantation. 57:1994;658-661
10. Ricordi C., Lacy P.E., Finke E.H., Olack B.J., Scharp D.W. Automated method for isolation of human pancreatic islets. Diabetes. 37:1988;413-420
11. International Islet Transplant Registry No. 9, 2001.
12. Bretzel R.G., Brandhorst D., Hering B.J., et al. Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management. J. Mol. Med. 77:1999;140-143
13. Jeong I.K., Lee M.K., Kim K.W., et al. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway. Exp. Mol. Med. 34:2002;12-17
14. Robertson G.S., Dennison A.R., Johnson P.R., Nicholas J.M. A review of pancreatic islet autotransplantation. Hepatogastroenterology. 45:1998;226-235
15. Mathew J.M., Garcia-Morales R., Fuller L., et al. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. Potent regulators of recipient antidonor immune responses. Transplantation. 70:2000;1675-1682
16. Yamada A., Sayegh M.H. The CD 154-CD40 co-stimulatory pathway in transplantation. Transplantation. 73:2002;s36-s39